Panacea Biotec Limited - Product Pipeline Review - 2016

  • ID: 3832330
  • Company Profile
  • 55 pages
  • Global Markets Direct
1 of 4
Panacea Biotec Limited - Product Pipeline Review - 2016

Summary

‘Panacea Biotec Limited - Product Pipeline Review - 2016’, provides an overview of the Panacea Biotec Limited’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Panacea Biotec Limited, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Panacea Biotec Limited
- The report provides overview of Panacea Biotec Limited including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Panacea Biotec Limited’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Panacea Biotec Limited’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Panacea Biotec Limited’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Panacea Biotec Limited
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Panacea Biotec Limited’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

Panacea Biotec Limited Snapshot

Panacea Biotec Limited Overview

Key Information

Key Facts

Panacea Biotec Limited - Research and Development Overview

Key Therapeutic Areas

Panacea Biotec Limited - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Combination Treatment Modalities

Panacea Biotec Limited - Pipeline Products Glance

Panacea Biotec Limited - Late Stage Pipeline Products

Phase III Products/Combination Treatment Modalities

Panacea Biotec Limited - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

Panacea Biotec Limited - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

Panacea Biotec Limited - Unknown Stage Pipeline Products

Unknown Products/Combination Treatment Modalities

Panacea Biotec Limited - Drug Profiles

(diphtheria + Haemophilus influenzae [serotype B] + hepatitis B + pertussis (whole cell) + polio + tetanus) (hexavalent) vaccine

Product Description

Mechanism of Action

R&D Progress

(diphtheria + Haemophilus influenzae [serotype B] + pertussis (whole cell) + polio + tetanus)(pentavalent) vaccine

Product Description

Mechanism of Action

R&D Progress

polio [strain Sabin] vaccine

Product Description

Mechanism of Action

R&D Progress

Nucovac

Product Description

Mechanism of Action

R&D Progress

bevacizumab biosimilar

Product Description

Mechanism of Action

R&D Progress

cetuximab biosimilar

Product Description

Mechanism of Action

R&D Progress

darbepoetin alfa

Product Description

Mechanism of Action

R&D Progress

etanercept biosimilar

Product Description

Mechanism of Action

R&D Progress

hepatitis B vaccine 2

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibodies for Cancer

Product Description

Mechanism of Action

R&D Progress

omalizumab biosimilar

Product Description

Mechanism of Action

R&D Progress

rituximab biosimilar

Product Description

Mechanism of Action

R&D Progress

Synthetic Peptide for Alopecia

Product Description

Mechanism of Action

R&D Progress

trastuzumab biosimilar

Product Description

Mechanism of Action

R&D Progress

dengue (tetravalent) vaccine

Product Description

Mechanism of Action

R&D Progress

influenza vaccine

Product Description

Mechanism of Action

R&D Progress

Japanese encephalitis vaccine

Product Description

Mechanism of Action

R&D Progress

meningococcal vaccine

Product Description

Mechanism of Action

R&D Progress

pertussis (acellular) vaccine

Product Description

Mechanism of Action

R&D Progress

pneumococcal vaccine

Product Description

Mechanism of Action

R&D Progress

respiratory syncytial virus vaccine

Product Description

Mechanism of Action

R&D Progress

Synthetic Peptides to Agonize GLP-1 for Type 2 Diabetes

Product Description

Mechanism of Action

R&D Progress

yellow fever vaccine

Product Description

Mechanism of Action

R&D Progress

Recombinant Protein for Autoimmune Disorders

Product Description

Mechanism of Action

R&D Progress

Recombinant Protein for Renal Anemia

Product Description

Mechanism of Action

R&D Progress

Panacea Biotec Limited - Pipeline Analysis

Panacea Biotec Limited - Pipeline Products by Target

Panacea Biotec Limited - Pipeline Products by Route of Administration

Panacea Biotec Limited - Pipeline Products by Molecule Type

Panacea Biotec Limited - Pipeline Products by Mechanism of Action

Panacea Biotec Limited - Recent Pipeline Updates

Panacea Biotec Limited - Dormant Projects

Panacea Biotec Limited - Company Statement

Panacea Biotec Limited - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer 55List of Tables

Panacea Biotec Limited, Key Information

Panacea Biotec Limited, Key Facts

Panacea Biotec Limited - Pipeline by Indication, 2016

Panacea Biotec Limited - Pipeline by Stage of Development, 2016

Panacea Biotec Limited - Monotherapy Products in Pipeline, 2016

Panacea Biotec Limited - Combination Treatment Modalities in Pipeline, 2016

Panacea Biotec Limited - Phase III, 2016

Panacea Biotec Limited - Phase II, 2016

Panacea Biotec Limited - Phase I, 2016

Panacea Biotec Limited - Preclinical, 2016

Panacea Biotec Limited - Discovery, 2016

Panacea Biotec Limited - Unknown, 2016

Panacea Biotec Limited - Pipeline by Target, 2016

Panacea Biotec Limited - Pipeline by Route of Administration, 2016

Panacea Biotec Limited - Pipeline by Molecule Type, 2016

Panacea Biotec Limited - Pipeline Products by Mechanism of Action, 2016

Panacea Biotec Limited - Recent Pipeline Updates, 2016

Panacea Biotec Limited - Dormant Developmental Projects,2016

Panacea Biotec Limited, Other Locations

Panacea Biotec Limited, Subsidiaries 53List of Figures

Panacea Biotec Limited - Pipeline by Top 10 Indication, 2016

Panacea Biotec Limited - Pipeline by Stage of Development, 2016

Panacea Biotec Limited - Monotherapy Products in Pipeline, 2016

Panacea Biotec Limited - Pipeline by Top 10 Target, 2016

Panacea Biotec Limited - Pipeline by Route of Administration, 2016

Panacea Biotec Limited - Pipeline by Top 10 Molecule Type, 2016

Panacea Biotec Limited - Pipeline Products by Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll